Fibroblast growth factor-23 (FGF-23), which, by increasing renal phosphate excretion and inhibiting 1,25-dihydroxyvitamin D synthesis, increases the risk for vascular calcification, was positively associated with MAC incidence and progression. The gene discussed is FGF23; the disease is mitral annular calcification.